Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Lonial, Sagar, Lee, Hans C, Badros, Ashraf, Trudel, Suzanne, Nooka, Ajay K, Chari, Ajai, Abdallah, Al-Ola, Callander, Natalie, Lendvai, Nikoletta, Sborov, Douglas, Suvannasankha, Attaya, Weisel, Katja, Karlin, Lionel, Libby, Edward, Arnulf, Bertrand, Facon, Thierry, Hulin, Cyrille, Kortüm, K Martin, Rodríguez-Otero, Paula, Usmani, Saad Z, Hari, Parameswaran, Baz, Rachid, Quach, Hang, Moreau, Philippe, Voorhees, Peter M, Gupta, Ira, Hoos, Axel, Zhi, Eric, Baron, January, Piontek, Trisha, Lewis, Eric, Jewell, Roxanne C, Dettman, Elisha J, Popat, Rakesh, Esposti, Simona Degli, Opalinska, Joanna, Richardson, Paul, Cohen, Adam D
Published in The lancet oncology (01.02.2020)
Published in The lancet oncology (01.02.2020)
Get full text
Journal Article
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma
Facon, Thierry, Kumar, Shaji, Plesner, Torben, Orlowski, Robert Z, Moreau, Philippe, Bahlis, Nizar, Basu, Supratik, Nahi, Hareth, Hulin, Cyrille, Quach, Hang, Goldschmidt, Hartmut, O’Dwyer, Michael, Perrot, Aurore, Venner, Christopher P, Weisel, Katja, Mace, Joseph R, Raje, Noopur, Attal, Michel, Tiab, Mourad, Macro, Margaret, Frenzel, Laurent, Leleu, Xavier, Ahmadi, Tahamtan, Chiu, Christopher, Wang, Jianping, Van Rampelbergh, Rian, Uhlar, Clarissa M, Kobos, Rachel, Qi, Ming, Usmani, Saad Z
Published in The New England journal of medicine (30.05.2019)
Published in The New England journal of medicine (30.05.2019)
Get full text
Journal Article
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
Burger, Jan A, Tedeschi, Alessandra, Barr, Paul M, Robak, Tadeusz, Owen, Carolyn, Ghia, Paolo, Bairey, Osnat, Hillmen, Peter, Bartlett, Nancy L, Li, Jianyong, Simpson, David, Grosicki, Sebastian, Devereux, Stephen, McCarthy, Helen, Coutre, Steven, Quach, Hang, Gaidano, Gianluca, Maslyak, Zvenyslava, Stevens, Don A, Janssens, Ann, Offner, Fritz, Mayer, Jiří, O’Dwyer, Michael, Hellmann, Andrzej, Schuh, Anna, Siddiqi, Tanya, Polliack, Aaron, Tam, Constantine S, Suri, Deepali, Cheng, Mei, Clow, Fong, Styles, Lori, James, Danelle F, Kipps, Thomas J
Published in The New England journal of medicine (17.12.2015)
Published in The New England journal of medicine (17.12.2015)
Get full text
Journal Article
Multiplex immunohistochemistry elucidates increased distance between cytotoxic T cells and plasma cells in relapsed myeloma, and identifies Lag-3 as the most common checkpoint receptor on cytotoxic T cells of myeloma patients
Ninkovic, Slavisa, Purton, Louise E, Harrison, Simon J, Quach, Hang
Published in Haematologica (Roma) (01.05.2024)
Published in Haematologica (Roma) (01.05.2024)
Get full text
Journal Article
Sustained minimal residual disease negativity in newly diagnosed multiple myeloma and the impact of daratumumab in MAIA and ALCYONE
San-Miguel, Jesus, Avet-Loiseau, Hervé, Paiva, Bruno, Kumar, Shaji, Dimopoulos, Meletios A., Facon, Thierry, Mateos, María-Victoria, Touzeau, Cyrille, Jakubowiak, Andrzej, Usmani, Saad Z., Cook, Gordon, Cavo, Michele, Quach, Hang, Ukropec, Jon, Ramaswami, Priya, Pei, Huiling, Qi, Mia, Sun, Steven, Wang, Jianping, Krevvata, Maria, DeAngelis, Nikki, Heuck, Christoph, Van Rampelbergh, Rian, Kudva, Anupa, Kobos, Rachel, Qi, Ming, Bahlis, Nizar J.
Published in Blood (27.01.2022)
Published in Blood (27.01.2022)
Get full text
Journal Article
Daratumumab plus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: frailty subgroup analysis of MAIA
Facon, Thierry, Cook, Gordon, Usmani, Saad Z., Hulin, Cyrille, Kumar, Shaji, Plesner, Torben, Touzeau, Cyrille, Bahlis, Nizar J., Basu, Supratik, Nahi, Hareth, Goldschmidt, Hartmut, Quach, Hang, Mohty, Mohamad, Venner, Christopher P., Weisel, Katja, Raje, Noopur, Hebraud, Benjamin, Belhadj-Merzoug, Karim, Benboubker, Lotfi, Decaux, Olivier, Manier, Salomon, Caillot, Denis, Ukropec, Jon, Pei, Huiling, Van Rampelbergh, Rian, Uhlar, Clarissa M., Kobos, Rachel, Zweegman, Sonja
Published in Leukemia (01.04.2022)
Published in Leukemia (01.04.2022)
Get full text
Journal Article
Comparison of EasyM, a clonotypic mass spectrometry assay, and EuroFlow minimal residual disease assessment in multiple myeloma
Zhao, Jessie, Khong, Tiffany, Gorniak, Malgorzata, Khaled, Abir, McDonald, Zac, Reynolds, John, Mithraprabhu, Sridurga, Bingham, Nicholas, Lim, Suehli, Wong, Daniel, Johnston, Anna, Motorna, Olga, Murphy, Nicholas, Quach, Hang, Yang, Liqiang, Spencer, Andrew
Published in Haematologica (Roma) (07.11.2024)
Published in Haematologica (Roma) (07.11.2024)
Get full text
Journal Article
Real‐world outcomes in relapsed refractory multiple myeloma patients exposed to three or more prior treatments: an analysis from the ANZ myeloma and related diseases registry
Lim, Sueh‐li, Wellard, Cameron, Moore, Elizabeth, Harrison, Simon J., Hang, Quach, Ho, Joy, Rajagopal, Rajeev, Spencer, Andrew
Published in Internal medicine journal (01.05.2024)
Published in Internal medicine journal (01.05.2024)
Get full text
Journal Article
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma
Gherardin, Nicholas A., Loh, Liyen, Admojo, Lorenztino, Davenport, Alexander J., Richardson, Kelden, Rogers, Amy, Darcy, Phillip K., Jenkins, Misty R., Prince, H. Miles, Harrison, Simon J., Quach, Hang, Fairlie, David P., Kedzierska, Katherine, McCluskey, James, Uldrich, Adam P., Neeson, Paul J., Ritchie, David S., Godfrey, Dale I.
Published in Scientific reports (07.03.2018)
Published in Scientific reports (07.03.2018)
Get full text
Journal Article
Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients
Mithraprabhu, Sridurga, Reynolds, John, Quach, Hang, Horvath, Noemi, Kerridge, Ian, Khong, Tiffany, Durie, Brian Gm, Spencer, Andrew
Published in Haematologica (Roma) (01.03.2024)
Published in Haematologica (Roma) (01.03.2024)
Get full text
Journal Article
Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells
Cooke, Rachel Elizabeth, Quinn, Kylie Margaret, Quach, Hang, Harrison, Simon, Prince, Henry Miles, Koldej, Rachel, Ritchie, David
Published in Frontiers in immunology (03.09.2020)
Published in Frontiers in immunology (03.09.2020)
Get full text
Journal Article
A multi-center, phase Ib study of subcutaneous administration of isatuximab in combination with pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
Quach, Hang, Parmar, Gurdeep, Ocio, Enrique M, Prince, H Miles, Oriol, Albert, Crowther, Helen, Tsukada, Nobuhiro, Bories, Pierre, Madan, Sumit, Nathwani, Nitya, Sunami, Kazutaka, Semiond, Dorothee, Yu, Disa, Cordero, Paul, Macé, Sandrine, Suzan, Florence, Moreau, Philippe
Published in Haematologica (Roma) (15.08.2024)
Published in Haematologica (Roma) (15.08.2024)
Get full text
Journal Article
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
Bergin, Krystal, Wellard, Cameron, Augustson, Bradley, Cooke, Rachel, Blacklock, Hilary, Harrison, Simon J., Ho, Joy, King, Tracy, Quach, Hang, Mollee, Peter, Walker, Patricia, Moore, Elizabeth, McQuilten, Zoe, Wood, Erica, Spencer, Andrew
Published in Bone marrow transplantation (Basingstoke) (01.10.2021)
Published in Bone marrow transplantation (Basingstoke) (01.10.2021)
Get full text
Journal Article
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR)
Bergin, Krystal, Wellard, Cameron, Moore, Elizabeth, McQuilten, Zoe, Blacklock, Hilary, Harrison, Simon J., Ho, P. Joy, King, Tracy, Quach, Hang, Mollee, Peter, Walker, Patricia, Wood, Erica, Spencer, Andrew
Published in Clinical lymphoma, myeloma and leukemia (01.06.2021)
Published in Clinical lymphoma, myeloma and leukemia (01.06.2021)
Get full text
Journal Article
The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy
Hsu, Andy K., Quach, Hang, Tai, Tsin, Prince, H. Miles, Harrison, Simon J., Trapani, Joseph A., Smyth, Mark J., Neeson, Paul, Ritchie, David S.
Published in Blood (03.02.2011)
Published in Blood (03.02.2011)
Get full text
Journal Article
Excellent outcomes in older patients with primary CNS lymphoma treated with R-MPV/cytarabine without whole brain radiotherapy or autologous stem cell transplantation therapy
Tatarczuch, Maciej, Paul, Erin, Gilberston, Michael, Gregory, Gareth P., Tam, Constantine, Quach, Hang, Bazargan, Ali, Filshie, Robin, Ku, Matthew, Tey, Amanda, Shortt, Jake, Opat, Stephen
Published in Leukemia & lymphoma (02.01.2021)
Published in Leukemia & lymphoma (02.01.2021)
Get full text
Journal Article
Carfilzomib, thalidomide, and dexamethasone is safe and effective in relapsed and/or refractory multiple myeloma: final report of the single arm, multicenter phase II ALLG MM018/AMN002 study
Ninkovic, Slavisa, Harrison, Simon J, Lee, Je-Jung, Murphy, Nick, Lee, Jae Hoon, Estell, Jane, Chen, Vivien M, Horvath, Noemi, Kim, Kihuyn, Eek, Richard, Augustson, Bradley, Bang, Soo-Mee, Huang, Shang-Yi, Rajagopal, Rajeev, Szabo, Ferenc, Engeler, Daniel, Butcher, Belinda E, Mollee, Peter, Durie, Brian, Chng, Wee Joo, Quach, Hang
Published in Haematologica (Roma) (18.01.2024)
Published in Haematologica (Roma) (18.01.2024)
Get full text
Journal Article
Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial
Dimopoulos, Meletios A., Schjesvold, Fredrik, Doronin, Vadim, Vinogradova, Olga, Quach, Hang, Leleu, Xavier, Montes, Yolanda Gonzalez, Ramasamy, Karthik, Pompa, Alessandra, Levin, Mark-David, Lee, Cindy, Mellqvist, Ulf Henrik, Fenk, Roland, Demarquette, Hélène, Sati, Hamdi, Vorog, Alexander, Labotka, Richard, Du, Jichang, Darif, Mohamed, Kumar, Shaji
Published in Blood cancer journal (New York) (24.01.2022)
Published in Blood cancer journal (New York) (24.01.2022)
Get full text
Journal Article
Myeloma natural killer cells are exhausted and have impaired regulation of activation
D’Souza, Criselle, Keam, Simon P., Yeang, Han Xian Aw, Neeson, Michael, Richardson, Kelden, Hsu, Andy K., Canfield, Rachael, Bezman, Natalie, Robbins, Michael, Quach, Hang, Ritchie, David S., Harrison, Simon J., Trapani, Joseph A., Prince, H. Miles, Beavis, Paul A., Darcy, Phillip K., Neeson, Paul J.
Published in Haematologica (Roma) (01.09.2021)
Published in Haematologica (Roma) (01.09.2021)
Get full text
Journal Article